Precancerous oral lesions can progress to oral cancer and are typically ablated or surgically removed as a preventive measure ...
A 75-year-old man with poorly differentiated adenocarcinoma in the right lower lobe received neoadjuvant carboplatin, paclitaxel, and nivolumab therapy. Although posttreatment CT scans suggested ...
Results from the MagnetisMM-5 study showed that Elrexfio significantly improved progression-free survival, which means ...
Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...
The FDA’s Oncologic Drugs Advisory Committee (ODAC) on Thursday voted 6 to 3 that AstraZeneca has not demonstrated its oral ...
Multidisciplinary tumor board endorsement enabled locoregional surgery and radiation in de novo metastatic disease, reflecting selective use of curative-intent paradigms in exceptional responders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results